Future efforts must prioritize multi-center trials for safety/PK profiling, biodegradable polymers with tunable degradation, and multi-omics biomarkers for personalized therapy
The SCT receptor seems to drive many of the side effects seen in other non-selective amylin agonists cough cagrilintide cough The shade in this slide is not subtle
The provider must consider the type of injury, tissue condition, treatment goal, and available medical evidence
This is particularly an issue in pediatric populations, where tools for predicting drug efficacy and developmental toxicity are not well established
Individuals on prescription brightening treatments (like hydroquinone or tretinoin): Discuss with your dermatologist to avoid over-treating and potential irritation
ERPs Integrate key ERP systems with ease, automating workflows and keeping your team aligned